Health and Wellness
Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.
The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.
AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.
Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic disease risk and aging.
The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring device.
The company also raised $5 million in venture debt funding.
Tampa General Hospital Cancer Institute will integrate Reimagine's platform into its clinical pathways to reduce workforce burden and extend cancer care into the home.
Executives pointed to faster-than-expected AI adoption in healthcare, shifting regulatory signals and growing demand for AI tools that deliver measurable outcomes.
The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.
The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.